Changchun Extrawell Pharmaceutical

Changchun Extrawell Pharmaceutical is a pharmaceutical company based in Changchun, China, and serves as a primary research and manufacturing subsidiary of Extrawell Pharmaceutical Holdings Limited. The company is best known for its long-standing development of an oral insulin enteric-coated soft capsule, a potential breakthrough in non-injectable diabetes treatment. Beyond its innovative pipeline, Changchun Extrawell produces and distributes a range of pharmaceutical products in the Chinese market. The company operates GMP-certified manufacturing facilities and focuses on metabolic diseases and general medicine. The company's operations are primarily focused on the Chinese domestic market, leveraging its specialized production lines for soft capsules. Changchun Extrawell has historically collaborated with prestigious institutions like Tsinghua University to advance its biotechnology programs.